c-MET
c-MET, also called MET, is a membrane receptor that is essential for embryonic development and wound healing.
Products for c-MET
- Cat.No. Product Name Information
-
BCC1054
AMG-208C-Met inhibitor,potent and highly selective
-
BCC1055
SGX-523Selective and potent c-MET kinase inhibitor
-
BCC1181
PHA-665752Potent and selective MET inhibitor
-
BCC1243
SU11274Selective inhibitor of MET kinase activity
-
BCC1264
Cabozantinib (XL184, BMS-907351)Potent VEGFR inhibitor; also inhibits other RTKs
-
BCC1284
(R)-CrizotinibPotent c-MET/ALK inhibitor
-
BCC1488
c-Met inhibitor 1Inhibitor of the c-Met receptor
-
BCC1550
EMD-1214063C-Met inhibitor,potent and selective
-
BCC1720
LY2801653MET inhibitor
-
BCC1721
LY2801653 dihydrochlorideMET inhibitor
-
BCC1768
MK-8033C-MET inhibitor
-
BCC1849
PF-04217903 methanesulfonateHighly selective MET inhibitor
-
BCC2020
Tyrosine kinase inhibitorTyrosine-kinase inhibitor
-
BCC2485
JNJ-38877605C-Met inhibitor,ATP-competitive
-
BCC2486
PF-04217903C-Met inhibitor,selective and ATP-competitive
-
BCC2538
BMS-777607C-Met inhibitor, potent and selective
-
BCC3688
Tivantinib (ARQ 197)C-Met inhibitor,non-ATP-competitive
-
BCC3721
AMG-458Potent c-Met inhibitor
-
BCC3793
INCB28060C-Met inhibitor,ATP-competitive and novel
-
BCC3828
NVP-BVU972C-Met inhibitor,potent and selective
-
BCC4040
MK-8033 hydrochlorideC-Met/Ron inhibitor
-
BCC4388
Cabozantinib malate (XL184)MET andVEGF receptor2 inhibitor
-
BCC4422
BMS-794833Met/VEGFR-2 inhibitor,potent and ATP-competitive
-
BCC4423
Golvatinib (E7050)C-Met/VEGFR-2 inhibitor
-
BCC5098
ZM 323881 HClPotent, selective inhibitor of VEGFR-2
-
BCC6385
Altiratinibc-MET/TIE-2/VEGFR inhibitor
-
BCC6413
BMS-817378Potent ATP competitive inhibitor of Met/VEGFR2
-
BCC6504
NPS-1034MET inhibitor
